News

Dispensed: Pharma middlemen get their day in the hot seat, life at Flatiron Health a year after acquisition, and almost $1 billion invested in clinical trial startups

Hello, Well, it’s official: Bristol-Myers Squibb and Celgene are likely going to form the megamerger of their dreams, after shareholders approved the $US74 billion union. Before heading into the weekend on that note, I wanted to leave you with a recap of all the news that kept Business Insider’s healthcare […]
Dispensed: Pharma middlemen get their day in the hot seat, life at Flatiron Health a year after acquisition, and almost $1 billion invested in clinical trial startups
Markets

Pharma giant Roche just made a $2.4 billion bet on cancer data

Roche on Tuesday bought the rest of Foundation Medicine, a company that collects genetic data from samples of cancer tissue or blood, for $US2.4 billion. Roche had held a majority stake in the company, and the deal values Foundation at $US5.3 billion. In February, Roche scooped up Flatiron Health, another […]
Pharma giant Roche just made a $2.4 billion bet on cancer data
Strategy

The 32-year-old who sold his first company for $80 million and a second for $2 billion talks about writing to Richard Branson, how he’s a terrible employee, and why he never intends to build companies to sell them

Nat Turner agreed to sell his company, Flatiron Health, to healthcare giant Roche in February for $US1.9 billion. Flatiron Health creates software for cancer centres that organizes patient data and makes some of it available to researchers, which supplements the results of clinical trials. Turner has been an entrepreneur since […]
The 32-year-old who sold his first company for $80 million and a second for $2 billion talks about writing to Richard Branson, how he’s a terrible employee, and why he never intends to build companies to sell them
Tech

Pharma giant Roche is buying cancer tech startup Flatiron Health for $1.9 billion

Pharma giant Roche is acquiring Flatiron Health for $US1.9 billion. The New York-based cancer technology startup had previously been valued at $US1.2 billion after raising $US175 million from investors including Roche. Flatiron collects clinical data from cancer patients – such as what medications patients have taken and how they have […]
Pharma giant Roche is buying cancer tech startup Flatiron Health for $1.9 billion